- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01353885
Outcomes Following Anterior Approach to Total Hip Arthroplasty (AAP)
August 12, 2014 updated by: McMaster University
Outcomes Following Anterior Approach to Total Hip Arthroplasty: A Multi-Centre Observational Cohort Study
Osteoarthritis disables approximately 10% of people who are 60 years or older and compromises the quality of life of more than 20 million Americans every year.
Osteoarthritis is caused by the breakdown of cartilage that lines the bones at your joints from daily wear and tear and results in pain and restricted function.
Total hip arthroplasty (THA) or total hip replacement, is currently one of the most successful and cost-effective treatments used to eliminate pain and restore function in those suffering from osteoarthritis.
There are multiple ways to perform a THA.
The main difference between each type is the point of incision in relation to a muscle on the outer surface of your hip bone: gluteus medius.
The incision performed can be anterior (in front of the muscle), anterolateral (in front and to the side of the muscle), or posterior (from the back).
Each of these approaches has its own advantages and disadvantages, but there is no evidence available that makes one better than the other.
The purpose of this study is to determine which of the three approaches to THA is the most effective.
The main outcome that will determine the most effective approach is the functional ability of the patients included in this study at 52 weeks.
The investigators will also compare whether the patient's: length of hospital stay, use of assistive devices, need for revision surgery, ability to return to work, ability to relieve pain, complication rate, and quality of life.
The investigators hypothesize that the anterior approach will be the most effective approach in reducing the rate of post-operative complications after THA.
Study Overview
Status
Terminated
Conditions
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Hamilton, Ontario, Canada, L8L 8E7
- McMaster University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Men or women who are 18 years of age or older with a primary diagnosis of hip arthritis (radiographically and clinically).
Patients must be undergoing an unilateral THA and have had no previous major hip surgery (hip arthroscopy is permitted) or hardware implanted in their hip.
Description
Inclusion Criteria:
- Men or women who are 18 years of age or older.
- Primary diagnosis of hip arthritis (radiographically and clinically).
- Patients undergoing an unilateral THA.
- Provision of informed consent by patient.
Exclusion Criteria:
- Patients being managed with alternative approaches (other than anterior, anterolateral or posterior THA) will be excluded.
- Patients undergoing a revision THA.
- Patients undergoing a bilateral THA.
- Patients with infection around the hip (soft tissue or bone).
- Patients who have had previous major hip surgery (hip arthroscopy is permitted) or hardware implanted in their hip.
- Patients who are currently enrolled in another surgical intervention trial.
- Patient has cognitive or language barriers that would limit completion of quality of life, pain, and function questionnaires in English.
- Anticipated problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Anterior Approach THA
500 Patients will be included who have received a total hip arthroplasty using the Anterior Approach.
The anterior approach to total hip arthroplasty refers to an internervous approach to the hip, where the incision is made from the middle of the iliac crest, then curved distally and laterally to the anterior superior iliac spine (Kelmanovich et al., 2003).
To optimize feasibility and applicability of our results, we will not standardize the use of cemented components, the implant manufacturer, or the femoral head size.
Surgeons will use the manufacturer specific guides for insertion of the total hip arthroplasty.
|
|
Posterior Approach THA
100 patients will be enrolled who have received a total hip arthroplasty using the posterior approach.
The posterior approach is performed by making a curved incision posteriorly on the greater trochanter (Jolles & Bogoch, 2004).
The fascia lata is then incised and the fibers of the gluteus maximus split using dissection (Jolles & Bogoch, 2004).
To ensure the feasibility and applicability of our findings, we will not standardize the use of cemented components, the implant manufacturer, or the femoral head size used in the posterior approach.
|
|
Anterolateral Approach THA
100 patients will be enrolled who have had a total hip arthroplasty using the anterolateral approach.
An anterolateral approach to THA utilizes an intermuscular approach by incising the patient posteriorly and distally to the anterior superior iliac spine, extending distally to the greater trochanter along the shaft of the femur (Kelmanovich et al., 2003).
To optimize the feasibility and applicability of our results, the implant manufacturer, femoral head size or the use of cemented components will not be standardized in this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Functional Ability
Time Frame: 52 Weeks
|
Measured by the Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaire.
|
52 Weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Technical Parameters
Time Frame: 1 day - measured during and post-operatively
|
Length of Incision (cm), Blood Loss (mL), Fluoroscopy Time (s), Operative Time (Min)
|
1 day - measured during and post-operatively
|
|
Length of Hospital Stay
Time Frame: 4 weeks
|
Duration of time patient is in hospital post-operatively.
|
4 weeks
|
|
Use of Assistive Device
Time Frame: 52 weeks
|
Presence of an assistive device(s) provided to patients at discharge and the length of time it takes the patient to discard the assistive device(s).
|
52 weeks
|
|
Revision Surgery
Time Frame: 52 weeks
|
Occurrence and type of revision surgery required (if any)
|
52 weeks
|
|
Ability to participate in sports activities
Time Frame: 52 weeks
|
Subjectively reported.
|
52 weeks
|
|
Return to Work
Time Frame: 52 Weeks
|
Measured by the Work Limitations Questionnaire (WLQ)- short form format
|
52 Weeks
|
|
Complication Rate
Time Frame: 52 Weeks
|
We will define complications in patients as a constellation of clinical symptoms and laboratory examinations.
These will include (but are not limited to) both intraoperative and postoperative complications; More specifically, musculoskeletal, cardiovascular, psychological, neurological, genitourinary, and wound-related complications.
|
52 Weeks
|
|
Pain
Time Frame: 52 Weeks
|
Measured by the EuroQol-5d (EQ-5D) and Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaires.
|
52 Weeks
|
|
Quality of Life
Time Frame: 52 Weeks
|
Measured by the EuroQol-5d (EQ-5D) and Hip Disability and Osteoarthritis Outcome Score (HOOS) questionnaires.
|
52 Weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Mohit Bhandari, MD, PhD, FRCSC, McMaster University
- Principal Investigator: Joel Matta, MD, St. Joseph's Health Centre
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
October 1, 2013
Study Completion (Actual)
October 1, 2013
Study Registration Dates
First Submitted
May 11, 2011
First Submitted That Met QC Criteria
May 12, 2011
First Posted (Estimate)
May 16, 2011
Study Record Updates
Last Update Posted (Estimate)
August 13, 2014
Last Update Submitted That Met QC Criteria
August 12, 2014
Last Verified
August 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Depuy-05072
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Hip
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip Osteoarthritis | Hip ArthropathyPoland
-
University of MiamiNot yet recruiting
-
Istituto Ortopedico RizzoliCompleted
-
Poznan University of Medical SciencesRecruiting
-
Tulip MedicineCompletedRehabilitation | Hip Osteoarthritis | Hip Arthroplasty Replacement | Hip Arthroplasty, TotalKazakhstan
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip OsteoarthritisPoland
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis
-
Artvin Coruh UniversityCompletedHip OsteoarthritisTurkey (Türkiye)